Edesa Biotech shareholders approved 2019 equity plan amendment at annual meeting

• Edesa Biotech held its annual general and special shareholder meeting on May 27, 2026.
• Shareholders adopted an amendment to the 2019 Equity Incentive Compensation Plan, adding 750,000 shares for issuance under the plan.
• The amendment also removed the plan’s annual per-participant option grant limit; the filing describes approval, not implementation steps.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edesa Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-003793), on May 29, 2026, and is solely responsible for the information contained therein.